top of page
![2[1]_edited.png](https://static.wixstatic.com/media/7ad897_5520b0601cf045dbba7d56a794486f75~mv2.png/v1/fill/w_100,h_100,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/2%5B1%5D_edited.png)
Navigating the "Prohibitive Risk" Frontier: A Contemporary Review of Mechanical Circulatory Support in Complex High-Risk Indicated Patient (CHIP) Interventions.
Original Research | 2025 | Volume 1 | Issue 1 | Page 60-69 Dr. Jambia Khatoon, Assistant Professor, Cardiology, IPGMER, Kolkata Abstract The definition of "revascularization candidates" has undergone a radical expansion, moving into the CHIP (Complex High-Risk Indicated Patient) domain. This population is defined by a "Triple Threat" of complex coronary anatomy (CTO, multivessel disease, severe calcification), severely depressed left ventricular function (LVEF < 35%), and pr
Deep Learning-Enhanced ECG Analysis for the Prediction of Occult Atrial Fibrillation: A Multi-Center Prospective Validation Study
Original Research | 2025 | Volume 1 | Issue 1 | Page 50-59 Dr. Sayama Prasad, Professor, Cardiology, GMC-Asam Dr. Arun Sharma, Professor, Cardiology, GMC-Jalgaow Abstract Background: Atrial Fibrillation (AFib) remains a leading cause of cryptogenic stroke due to its often paroxysmal and asymptomatic ("occult") nature. Traditional screening relies on symptomatic presentation or prolonged Holter monitoring, which often fails to capture intermittent episodes. This study evaluat
The Convergence of Robotics and Artificial Intelligence in Percutaneous Coronary Intervention: A 2026 Vision of Autonomous Revascularization
Review Paper | 2025 | Volume 1 | Issue 1 | Page 40-49 Dr. Abhisekh Gangauly, Lecturer, Department of Cardiology, IPGMER, Kolkata Abstract The traditional practice of Percutaneous Coronary Intervention (PCI) is currently undergoing a dual transformation, shifting from manual, tactile-dependent maneuvers to a high-precision, digitalized framework. This review evaluates the clinical and technical convergence of Robotic-Assisted PCI (R-PCI) and Artificial Intelligence (AI) , a s
Future Horizons: Nanotechnology and Gene Therapy
Review Paper | 2025 | Volume 1 | Issue 1 | Page 17-25 Dr. Amrish Singh, Lecturer, Department of Genetics, SNS College, Nawada Abstract As we approach the 2030 threshold, the paradigm of interventional cardiology is shifting from mechanical restoration to biological rejuvenation. The final frontier of "NextGen" cardiology lies in the integration of Nanotechnology and Gene Therapy, moving beyond the macro-scale of stents and valves into the sub-cellular environment. This chapte
Pharmacology in the Era of Intervention
Review Paper | 2026 | Volume 2 | Issue 1 | Page 84-88 Dr. Abhimita Singh, Professor, Cardiology, JMCH, Jalgwao, MP Abstract While mechanical and robotic innovations have redefined the physical landscape of the catheterization lab, the success of these procedures remains inextricably linked to advanced Pharmacotherapy. The "NextGen" era of intervention is not just about the hardware of stents and valves, but the biological management of the blood-surface interface. This chapte
bottom of page